Medicare Enrolled

Dr. Mario Sznol, MD

Medical Oncology · North Miami, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2111 SOLE MIA WAY, North Miami, FL 33181
7863927653
Registered in NPPES since 2005
NPI: 1073501748 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sznol from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sznol? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sznol

Dr. Mario Sznol is a medical oncology specialist in North Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sznol performed 471 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Sznol received a total of $170,303 from 32 pharmaceutical and/or device companies across 145 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sznol is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 471 Medicare services $170,303 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
471
Medicare services
Bottom 32% in FL for medical oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 258 $53 $255
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 150 $81 $375
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
 51 $119 $495
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
 12 $64 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$170,303
Total received (2018-2024)
Avg $24,329/year across 7 years
Top 6% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
145
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$22,418
2023
$18,950
2022
$38,534
2021
$30,489
2020
$15,492
2019
$19,900
2018
$24,519

Payments by company (2024)

Teva Pharmaceuticals USA, Inc.
$11,400
Regeneron Pharmaceuticals, Inc.
$8,221
PFIZER INC.
$1,875
E.R. Squibb & Sons, L.L.C.
$922
Top 3 companies account for 95.9% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Pharmaceuticals, Inc.
$28,192
E.R. Squibb & Sons, L.L.C.
$26,507
Incyte Corporation
$18,758
BioNTech SE
$11,988
Teva Pharmaceuticals USA, Inc.
$11,400
Innate Pharma, Inc
$7,920
AbbVie, Inc.
$7,425
JAZZ PHARMACEUTICALS INC.
$5,975
Verastem, Inc.
$5,911
ARRAY BIOPHARMA INC
$5,625
Merck Sharp & Dohme LLC
$5,450
Alkermes, Inc.
$4,720
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,550
Genentech USA, Inc.
$4,505
Gilead Sciences, Inc.
$3,400
Sumitomo Pharma America, Inc.
$2,720
Seattle Genetics, Inc.
$2,468
Genentech, Inc.
$2,145
GlaxoSmithKline, LLC.
$1,950
PFIZER INC.
$1,875
Kadmon Corporation LLC
$1,800
Anaeropahrma Science, Inc.
$1,200
AstraZeneca UK Limited
$1,000
SANOFI-AVENTIS U.S. LLC
$900
Partner Therapeutics, Inc.
$700
Chugai Pharmaceutical Co., Ltd.
$660
CLINIGEN, INC.
$157
Clinigen Inc
$145
Prometheus Laboratories Inc.
$114
Clinigen, Inc.
$89
F. Hoffmann-La Roche AG
$44
Merck Sharp & Dohme Corporation
$10
Top 3 companies account for 43.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · APS001F · Avastin · BRAFTOVI · Copiktra · Defactinib · JZP-815 · LEUKINE · LIBTAYO · Lumoxiti · Non-Covered Product · OPDIVO · PROLEUKIN · Proleukin · TECENTRIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in North Miami?
Compare medical oncologists in the North Miami area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
39
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA AVENTURA HOSPITAL
4.5 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sznol is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sznol experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Sznol performed 258 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sznol receive payments from pharmaceutical companies?
Yes. Dr. Sznol received a total of $170,303 from 32 companies across 145 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sznol's costs compare to other medical oncologists in North Miami?
Dr. Sznol's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sznol) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Medical Oncologists in North Miami
Browse medical oncologists in North Miami ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Regeneron Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →